News Conference News ESC 2019 DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics Shelley Wood September 01, 2019
News Conference News ESC 2019 PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen Todd Neale September 01, 2019
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News RELAX-AHF-2: Lack of Benefit With Serelaxin in Acute HF Still a Puzzle for Investigators L.A. McKeown August 21, 2019
News Daily News Best Strategy Questioned for NSTE ACS Patients With Prior CABG Shelley Wood August 05, 2019
News Daily News RAS Inhibition After TAVR Gains More Support, but RCT Still Needed Todd Neale July 29, 2019
News Daily News Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis Shelley Wood July 23, 2019
News Industry News SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent July 23, 2019
News Daily News Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall Marcus A. Banks July 12, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019